Frequently Asked Questions

I-ONE^® therapy is a biophysical stimulation device which controls inflammation at the joint (cartilage, subchondral bone and synovia).

I-ONE^® therapy is specially designed for the joint.

In the presence of cartilage lesions, I-ONE^® therapy effectively controls inflammation, protects cartilage and, in the presence of cartilage lesions, maintains the mechanical competence. These positive effects are maintained in the long term, resulting in with patient' satisfaction.

I-ONE^® therapy delivers a pulsed electromagnetic field able to interact with all joint structures. 
It performs like a medication reducing pain and swelling without side effects.

I-ONE^® therapy prevents and reduces the negative impact of inflammation on the joint by stimulating the activity of a molecule present in our body (adenosine) thereby reducing the inflammatory process and ensuring the integrity of all joint structures.

I-ONE^® therapy prevents the damaging effects of inflammation on cartilage resulting in joint chondroprotection.

Activate I-ONE^® therapy by pressing the power button for about 2 seconds (until a confirmation beep is heard), a LED with a steady green light will illuminate and the words "IGEA" and "I-ONE" will appear on the display and the therapy will ten commence.

At this point the green light will flash and the display will show a time that indicates the duration of the therapy performed. The timer is updated minute by minute until the recommended daily therapy time of 4 hours is completed.

Once the daily therapy time is reached, the system emits 3 "beeps" and stops dispensing the therapy. The green light becomes fixed and the time flashes showing that the daily therapy time (4 hours) has been completed.

Yes.

Its biological and electrical safety are widely documented.

Thousands of patients have successfully used I-ONE^® therapy in the absence of negative side effects.

I-ONE^® therapy is manufactured in compliance with the IEC 60601-1 standards, meets the requirements of directive 93/42/EEC and it is CE0051 marked.

The patient does not feel the presence of the electromagnetic field generated by I-ONE^® therapy.

The treatment does not interfere with daily activities. I-ONE^® therapy is light and portable and easy to use regardless of the anatomical site to be treated.

To guarantee the effectiveness of the therapy, the treatment parameters (in compliance with the CEI EN 60601-1-11 standard) are preset and can not be changed, even accidentally, by the patient.

Yes, in fact it is not advisable to put the applied part (coil) in direct contact with the skin.

We would advise placing the applied part (coil) on top of clothing or dressing.

Daily treatment with I-ONE^® therapy must be 4 hours (not necessarily consecutive).

The attending physician will specify the total duration of the therapy in accordance to the pathology being treated.

No, treatment can be carried out at any time of day.

Daily treatment may be split into several shorter sessions, provided they are at least 2 hours per session.

It is advised to recommence the treatment program as soon as possible.

Treatment length depends on the severity and of the disease.

The doctor prescribes the duration of the therapy based on his experience and on the results of clinical trials.

Before discontinuing therapy, even if there are clear signs of improvement, it is always necessary to firstly consult your doctor.

The constant daily use of I-ONE^® therapy and the continuity of treatment until recovery is essential to promote the healing process.

Yes, however coils should be positioned at least 50 cm away from pace-maker.

In this situation, Cardiologist advice is recommended. 

The effects of I-ONE^® therapy pulsed electromagnetic fields during pregnancy have not been investigated and, therefore, Physician advice is recommended. 

RENTAL

I-ONE^® therapy is prepared and shipped to patients ready for use. No intervention or maintenance is required.

PURCHASE

To guarantee the reliability of the performance, I-ONE^® therapy, should be subjected to an ordinary maintenance procedures and a control of the operating parameters (to be performed by the IGEA Service Centre) every 24 months of use (Guide IEC 62-122).

I-ONE^® therapy has no contraindications or side effects.

The experience gained in treating thousand of patients guarantees the safety of all IGEA therapies.

In patients with oncological diseases the use of I-ONE^® therapy is not contraindicated. 

However, we would advise you to consult your doctor.